Cargando…

Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis

Coronavirus disease 2019 (COVID-19) following primary immunization (breakthrough infection) has been reported in hemodialysis patients; however, their post-infection immune status remains unclear. We evaluated the humoral and cellular immunity of hemodialysis patients after breakthrough infection. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toda, Masataro, Yoshifuji, Ayumi, Nakayama, Tetsuo, Mise-Omata, Setsuko, Oyama, Emi, Uwamino, Yoshifumi, Namkoong, Ho, Komatsu, Motoaki, Yoshimura, Akihiko, Hasegawa, Naoki, Kikuchi, Kan, Ryuzaki, Munekazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384632/ https://www.ncbi.nlm.nih.gov/pubmed/37515030 http://dx.doi.org/10.3390/vaccines11071214

Ejemplares similares

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022)

Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022)

Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19
por: Toda, Masataro, et al.
Publicado: (2022)

Minimal Change Disease Associated With Durvalumab
por: Toda, Masataro G., et al.
Publicado: (2021)

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients
por: Toda, Masataro, et al.
Publicado: (2021)

Chryseobacterium indologenes Peritonitis in a Peritoneal Dialysis Patient: A Case Report and Review of Literature
por: Miyakawa, Akira, et al.
Publicado: (2023)

Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination
por: Uwamino, Yoshifumi, et al.
Publicado: (2023)

Glomerulonephritis Caused by Bartonella spp. Infective Endocarditis: The Difficulty and Importance of Differentiation from Anti-neutrophil Cytoplasmic Antibody-related Rapidly Progressive Glomerulonephritis
por: Yoshifuji, Ayumi, et al.
Publicado: (2021)

A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma
por: Kato, Ai, et al.
Publicado: (2022)

COVID-19 vaccine induced interstitial lung disease
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy
por: Chikuma, Shunsuke, et al.
Publicado: (2017)

Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis
por: Yoshifuji, Ayumi, et al.
Publicado: (2023)

Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory–Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand
por: Ando, Makoto, et al.
Publicado: (2021)

Reduced T Cell Response in Carcinogen‐sensitive Donryu Rats Compared with Carcinogen‐resistant DRH Rats
por: Mise‐Omata, Setsuko, et al.
Publicado: (1999)

Generation and application of human induced‐stem cell memory T cells for adoptive immunotherapy
por: Kondo, Taisuke, et al.
Publicado: (2018)

Humoral and cellular immune response dynamics in Japanese healthcare workers up to six months after receiving a third dose of BNT162b2 monovalent vaccine
por: Uwamino, Yoshifumi, et al.
Publicado: (2023)

Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

R-CHOP Chemotherapy for Disseminated Mycobacterium avium Complex Disease due to Anti-Interferon-Gamma Autoantibodies: A Case Report
por: Uno, Shunsuke, et al.
Publicado: (2021)

Peripheral tolerance by Treg via constraining OX40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus
por: Iriki, Hisato, et al.
Publicado: (2021)

Clinical and Pathological Characteristics of Elderly Japanese Patients with IgA Vasculitis with Nephritis: A Case Series
por: Ueda, Hiroyuki, et al.
Publicado: (2018)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan
por: Takeshita, Masaru, et al.
Publicado: (2021)

SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
por: Pušnik, Jernej, et al.
Publicado: (2023)

Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients
por: Chumsri, Saranya, et al.
Publicado: (2021)

Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
por: Lee, Chan Mi, et al.
Publicado: (2023)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Fabrication and Evaluation of Trimethylmethoxysilane (TMMOS)-Derived Membranes for Gas Separation
por: Mise, Yoshihiro, et al.
Publicado: (2019)

Breakthrough!
por: KURNIT, Paul
Publicado: (2010)

Peptide drugs accelerate BMP‐2‐induced calvarial bone regeneration and stimulate osteoblast differentiation through mTORC1 signaling
por: Sugamori, Yasutaka, et al.
Publicado: (2016)

Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis
por: Uno, Shunsuke, et al.
Publicado: (2020)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
por: Chinnadurai, Rajkumar, et al.
Publicado: (2022)

Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
por: Ruhl, Louisa, et al.
Publicado: (2023)

The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
por: Cohen, Idan, et al.
Publicado: (2023)

Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study
por: Kikuchi, Kan, et al.
Publicado: (2021)

Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire survey
por: Sugawara, Yuka, et al.
Publicado: (2021)

Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities
por: Sugawara, Yuka, et al.
Publicado: (2021)

COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia
por: Yang, Su Lan, et al.
Publicado: (2022)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated
por: Maaske, Jill, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f8jgorf4qte3d1dgv9u2rulc66